It doesn't build muscle, alter hormone levels, or act as a performance-enhancing drug
Dysbiosis impairs the intestinal barrier, increasing its permeability and allowing bacteria and lipopolysaccharides (LPS) from the gut to translocate into the systemic circulation, leading to systemic inflammation (148)
ALS/Riluzole Study Group
A doctor will only administer it if the potential benefits outweigh the risks.
No they are related but distinct molecules
David Ricks, Eli Lillys chair and CEO, commented on the investment, stating, This new $5.3 billion investment tops the largest manufacturing investment in our companys history and, we believe, represents the single largest investment in synthetic medicine API manufacturing in US history